Skip to content

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Etiology, Prevention, and Treatment of Neonatal Infections in the Community

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00198627
Enrollment
16359
Registered
2005-09-20
Start date
2003-12-31
Completion date
2007-09-30
Last updated
2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Infection, Infectious Disease

Keywords

Neonatal bacterial infection

Brief summary

The purpose of this study is to determine what are the major types of bacteria that cause newborn infections in the community in rural Bangladesh and whether providing an obstetric and neonatal care package will reduce neonatal deaths by 40%.

Detailed description

The study seeks answers to two questions: 1. What are the major bacterial pathogens responsible for serious neonatal infections in the community in rural Bangladesh? 2. Can provision of a package of obstetric and neonatal care, including active surveillance for serious neonatal illness and referral to hospital, and identification of barriers to care-seeking and design of strategies to address them reduce neonatal mortality rates by at least 40% compared to communities in which such services are not provided? Despite significant decline in infant and child mortality rates in recent decades, neonatal mortality rates remain unacceptably high. Of the 8 million infant deaths that occur worldwide each year, approximately 4 million occur in the neonatal period. Hence, the specific aims of the study include: 1. identifying the principal agents of serious bacterial infections in Bangladeshi neonates in the community 2. evaluating the impact of introducing a package of essential obstetric and neonatal care practices in the community, including identifying barriers to care-seeking and design of strategies to address those barriers and 3. building capacity within Bangladesh by training Bangladeshi scientists in epidemiological and microbiological techniques, clinical research methods and best clinical practice through an on-going collaboration with Dhaka Shishu (Children) Hospital and the International Centre for Diarrhoeal Disease Research, Bangladesh.

Interventions

DRUGCo-Trimoxazole; TMP-SMZ

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* pregnant women (any age) * newborns

Exclusion criteria

* children (outside newborn period)

Design outcomes

Primary

MeasureTime frame
Health workers will visit households at three month intervals for 18 months and survey the status of the babies.

Secondary

MeasureTime frame
At anytime during the study, if the baby shows symptoms of serious infection, the health worker will offer advice on where to go for treatment, or offer to treat the baby at home.

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026